Tuan Le Mau
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$18.4MFederal grants as PI19 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
19 awards · $18.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 10, 2026 | NIH | SBIR Phase II Developing an Elderly Patient-Specific, Accurate, Intuitive and Highly Interpretable System for Unconsciousness Management in General Anesthesia Using PASCALL FDA-Cleared Intraoperative EEG Monitor | $1.1M | PASCALL Systems, Incorporated |
| Jun 25, 2026 | NIH | STTR Phase II Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patients | $999K | PASCALL Systems, Incorporated |
| Jun 3, 2026 | NIH | SBIR Phase II Developing an Intraoperative EEG-Guided Precision Anesthesia Management System to Prevent Postoperative Delirium in Elderly and Patients at Risk for Alzheimer's & Related Dementias | $1.5M | PASCALL Systems, Incorporated |
| Jun 3, 2026 | NIH | SBIR Phase II Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias | $1.2M | PASCALL Systems, Incorporated |
| Sep 19, 2025 | NIH | SBIR Phase II Developing an Elderly Patient-Specific, Accurate, Intuitive and Highly Interpretable System for Unconsciousness Management in General Anesthesia Using PASCALL FDA-Cleared Intraoperative EEG Monitor | $1.1M | PASCALL Systems, Incorporated |
| Aug 25, 2025 | NIH | STTR Phase II Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patients | $998K | PASCALL Systems, Incorporated |
| Aug 14, 2025 | NIH | STTR Phase II Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care | $1.3M | PASCALL Systems, Incorporated |
| Jul 29, 2025 | NIH | SBIR Phase II Developing an Intraoperative EEG-Guided Precision Anesthesia Management System to Prevent Postoperative Delirium in Elderly and Patients at Risk for Alzheimer's & Related Dementias | $1.5M | PASCALL Systems, Incorporated |
| May 13, 2025 | NIH | SBIR Phase II Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias | $1.2M | PASCALL Systems, Incorporated |
| Sep 18, 2024 | NIH | SBIR Phase II Developing an Elderly Patient-Specific, Accurate, Intuitive and Highly Interpretable System for Unconsciousness Management in General Anesthesia Using PASCALL FDA-Cleared Intraoperative EEG Monitor | $399K | PASCALL Systems, Incorporated |
| Aug 26, 2024 | NIH | STTR Phase II Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care | $1.2M | PASCALL Systems, Incorporated |
| Aug 7, 2024 | NIH | SBIR Phase II Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias | $500K | PASCALL Systems, Incorporated |
| Jul 26, 2024 | NIH | STTR Phase II Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia to minimize postoperative opioid requirements | $221K | PASCALL Systems, Incorporated |
| Jul 1, 2024 | NIH | STTR Phase II Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements | $988K | PASCALL Systems, Incorporated |
| Jun 26, 2023 | NIH | STTR Phase II Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements | $982K | PASCALL Systems, Incorporated |
| Feb 16, 2022 | NIH | STTR Phase II Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients | $1.2M | PASCALL Systems, Incorporated |
| Feb 26, 2021 | NIH | STTR Phase II Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients | $1.2M | PASCALL Systems, Incorporated |
| Sep 15, 2020 | NIH | STTR Phase II Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements | $350K | PASCALL Systems, Incorporated |
| Jan 31, 2020 | NIH | STTR Phase II Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients | $450K | PASCALL Systems, Incorporated |
Peer ranks
Federal funding#12
Awards as PI#32
Patents#505
Companies
- PASCALL Systems, IncorporatedLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.